637 related articles for article (PubMed ID: 25034030)
1. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
2. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.
Tsuda H; Kawada N; Kaimori JY; Kitamura H; Moriyama T; Rakugi H; Takahara S; Isaka Y
Biochem Biophys Res Commun; 2012 Oct; 427(2):266-72. PubMed ID: 22995295
[TBL] [Abstract][Full Text] [Related]
3. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.
Jeong KH; Lee TW; Ihm CG; Lee SH; Moon JY; Lim SJ
Am J Nephrol; 2009; 29(3):274-82. PubMed ID: 18812693
[TBL] [Abstract][Full Text] [Related]
4. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
5. The Protective Effect of Febuxostat on Chronic Tacrolimus-Induced Nephrotoxicity in Rats.
Kim HS; Lim SW; Jin L; Jin J; Chung BH; Yang CW
Nephron; 2017; 135(1):61-71. PubMed ID: 27701176
[TBL] [Abstract][Full Text] [Related]
6. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
7. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
8. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy.
Lee SH; Nam BY; Kang EW; Han SH; Li JJ; Kim DH; Kim SH; Kwak SJ; Park JT; Chang TI; Yoo TH; Han DS; Kang SW
Nephrol Dial Transplant; 2010 Jul; 25(7):2134-41. PubMed ID: 20157172
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats.
Altinoz E; Oner Z; Elbe H; Cigremis Y; Turkoz Y
Hum Exp Toxicol; 2015 Feb; 34(2):127-34. PubMed ID: 24925368
[TBL] [Abstract][Full Text] [Related]
10. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Fahmi AN; Shehatou GS; Shebl AM; Salem HA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
12. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
[TBL] [Abstract][Full Text] [Related]
13. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
14. The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model.
Iskender H; Dokumacioglu E; Sen TM; Ince I; Kanbay Y; Saral S
Biomed Pharmacother; 2017 Jun; 90():500-508. PubMed ID: 28395272
[TBL] [Abstract][Full Text] [Related]
15. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
Xu HL; Wang XT; Cheng Y; Zhao JG; Zhou YJ; Yang JJ; Qi MY
Biomed Pharmacother; 2018 Sep; 105():915-921. PubMed ID: 30021385
[TBL] [Abstract][Full Text] [Related]
17. Ferulsinaic acid attenuation of diabetic nephropathy.
Sayed AA
Eur J Clin Invest; 2013 Jan; 43(1):56-63. PubMed ID: 23190272
[TBL] [Abstract][Full Text] [Related]
18. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
Omori H; Kawada N; Inoue K; Ueda Y; Yamamoto R; Matsui I; Kaimori J; Takabatake Y; Moriyama T; Isaka Y; Rakugi H
Clin Exp Nephrol; 2012 Aug; 16(4):549-56. PubMed ID: 22350467
[TBL] [Abstract][Full Text] [Related]
19. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus.
Fadillioglu E; Kurcer Z; Parlakpinar H; Iraz M; Gursul C
Arch Pharm Res; 2008 Jun; 31(6):705-12. PubMed ID: 18563351
[TBL] [Abstract][Full Text] [Related]
20. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Sánchez-Lozada LG; Tapia E; Bautista-García P; Soto V; Avila-Casado C; Vega-Campos IP; Nakagawa T; Zhao L; Franco M; Johnson RJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F710-8. PubMed ID: 18216151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
